Tavakoli N, Fong E, Coleman A, Huang Y, Bigger M, Doche M
NPJ Syst Biol Appl. 2025; 11(1):12.
PMID: 39875420
PMC: 11775273.
DOI: 10.1038/s41540-025-00494-1.
Cui J, Ma J, Gao X, Sheng Z, Pan Z, Shi L
World J Gastrointest Oncol. 2024; 16(12):4565-4578.
PMID: 39678792
PMC: 11577382.
DOI: 10.4251/wjgo.v16.i12.4565.
Urbaniec-Stompor J, Michalak M, Godlewski J
Int J Mol Sci. 2024; 25(18).
PMID: 39337393
PMC: 11432200.
DOI: 10.3390/ijms25189905.
Secchia S, Beilinson V, Chen X, Yang Z, Wayman J, Dhaliwal J
bioRxiv. 2024; .
PMID: 39314475
PMC: 11418948.
DOI: 10.1101/2024.09.06.611754.
Tian Y, Jiang Y, Ma P, Ma X, Du L, Wang F
Front Oncol. 2024; 14:1442601.
PMID: 39281380
PMC: 11392730.
DOI: 10.3389/fonc.2024.1442601.
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development.
Varveri A, Papadopoulou M, Papadovasilakis Z, Compeer E, Legaki A, Delis A
Nat Commun. 2024; 15(1):4988.
PMID: 38862534
PMC: 11167033.
DOI: 10.1038/s41467-024-49282-1.
Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease.
Vilardi A, Przyborski S, Mobbs C, Rufini A, Tufarelli C
Cell Death Discov. 2024; 10(1):258.
PMID: 38802341
PMC: 11130177.
DOI: 10.1038/s41420-024-02015-1.
Colorectal Liver Metastasis: Can Cytokines Make the Difference?.
Ballaro C, Quaranta V, Giannelli G
Cancers (Basel). 2023; 15(22).
PMID: 38001618
PMC: 10670198.
DOI: 10.3390/cancers15225359.
Molecular mechanisms in colitis-associated colorectal cancer.
Zhou R, Harpaz N, Itzkowitz S, Parsons R
Oncogenesis. 2023; 12(1):48.
PMID: 37884500
PMC: 10603140.
DOI: 10.1038/s41389-023-00492-0.
Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota.
Li J, Ji Y, Chen N, Dai L, Deng H
Cell Biosci. 2023; 13(1):194.
PMID: 37875976
PMC: 10594787.
DOI: 10.1186/s13578-023-01139-8.
A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment.
De Vlieghere E, Van de Vijver K, Blondeel E, Carpentier N, Ghobeira R, Pauwels J
Biomater Res. 2023; 27(1):104.
PMID: 37853495
PMC: 10583378.
DOI: 10.1186/s40824-023-00441-3.
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies.
He K, Wang Z, Luo M, Li B, Ding N, Li L
J Transl Med. 2023; 21(1):612.
PMID: 37689664
PMC: 10493031.
DOI: 10.1186/s12967-023-04460-5.
Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response.
Yau J, Adriani G
Front Oncol. 2023; 13:1148930.
PMID: 37469395
PMC: 10352797.
DOI: 10.3389/fonc.2023.1148930.
Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics.
Gu L, Ding D, Wei C, Zhou D
Front Oncol. 2023; 13:1158863.
PMID: 37404754
PMC: 10316023.
DOI: 10.3389/fonc.2023.1158863.
Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review.
Moslehian M, Shabkhizan R, Asadi M, Bazmani A, Mahdipour M, Haiaty S
BMC Cancer. 2023; 23(1):512.
PMID: 37280524
PMC: 10243085.
DOI: 10.1186/s12885-023-11008-9.
Metastatic colorectal cancer: mechanisms and emerging therapeutics.
Shin A, Giancotti F, Rustgi A
Trends Pharmacol Sci. 2023; 44(4):222-236.
PMID: 36828759
PMC: 10365888.
DOI: 10.1016/j.tips.2023.01.003.
Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas.
Dong J, Wang F, Gao X, Zhao H, Zhang J, Wang N
Front Oncol. 2023; 12:977251.
PMID: 36727078
PMC: 9885112.
DOI: 10.3389/fonc.2022.977251.
Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?.
Mirza S, Bhadresha K, Mughal M, McCabe M, Shahbazi R, Ruff P
Front Oncol. 2023; 12:1023565.
PMID: 36686736
PMC: 9853908.
DOI: 10.3389/fonc.2022.1023565.
Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer.
Villeger R, Chulkina M, Mifflin R, Markov N, Trieu J, Sinha M
Br J Cancer. 2022; 128(4):537-548.
PMID: 36482184
PMC: 9938173.
DOI: 10.1038/s41416-022-02066-0.
TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development.
Li X, Wu Y, Tian T
Int J Mol Sci. 2022; 23(22).
PMID: 36430910
PMC: 9698504.
DOI: 10.3390/ijms232214436.